Jump to main content
Jump to site search


Effect of Ganoderma atrum polysaccharide against pancreatic damage in streptozotocin-induced diabetic mice

Abstract

This study aimed to explore the role of Ganoderma atrum polysaccharide (PSG-1) on pancreatic damage in streptozotocin (STZ)-induced type 1 diabetes mellitus (T1DM) mice. Results suggested that blood glucose was significantly increased in STZ group in comparison with control group. After 4 weeks treatment with PSG-1 or metformin (MET), blood glucoses in PSG-1 and MET group were apparently lower than STZ group, indicating that PSG-1 triggered hypoglycemic effect in vivo. Moreover, experiments demonstrated that PSG-1 markedly decreased apoptosis of islet cells by inhibiting mitochondrial apoptotic pathway and activating PI3K/Akt survival pathway. PSG-1 also exerted anti-inflammatory effects, as evidences by dramatically reducing levels of IL-1β, TNF-α and INF-γ and restraining TLR4-dependent NF-κB signal pathway. Meanwhile, PSG-1 maintained homeostasis of redox system by increasing activities of anti-oxidant enzymes and reducing malondialdehyde contents in pancreas. Together, these data provided evidence that PSG-1 could be employed as an alternative dietary supplement to ameliorate T1DM.

Back to tab navigation

Publication details

The article was received on 28 Aug 2019, accepted on 26 Sep 2019 and first published on 27 Sep 2019


Article type: Paper
DOI: 10.1039/C9FO01990A
Food Funct., 2019, Accepted Manuscript

  •   Request permissions

    Effect of Ganoderma atrum polysaccharide against pancreatic damage in streptozotocin-induced diabetic mice

    L. Li, R. Li, Y. Song, W. Wu, S. Yin, W. Fu, R. Wu and W. li, Food Funct., 2019, Accepted Manuscript , DOI: 10.1039/C9FO01990A

Search articles by author

Spotlight

Advertisements